Abstract

Cigarette smoking causes serious diseases through frequent and prolonged exposure to toxicants. Technologies are being developed to reduce smokers’ toxicant exposure, including filter adsorbents, tobacco treatments and substitutes. This study examined the effect of modifications to filter ventilation, variations in cigarette circumference and active charcoal filter length and loading, as well as combinations of these features in a reduced-toxicant prototype (RTP) cigarette, on the yields of toxicants in cigarette smoke. An air-dilution mechanism, called split-tipping, was developed in which a band of porous paper in the centre of the filter tipping functions to minimise the loss of effective filter ventilation that occurs at the high flow rates encountered during human-smoking, and to facilitate the diffusional loss of volatile toxicants. As compared with conventional filter ventilation cigarettes, split-tipping reduced tar and volatile smoke constituent emissions under high flow rate machine-smoking conditions, most notably for products with a 1-mg ISO tar yield. Furthermore, mouth level exposure (MLE) to tar and nicotine was reduced among smokers of 1-mg ISO tar cigarettes in comparison to smokers of cigarettes with traditional filter ventilation. For higher ISO tar level cigarettes, however, there were no significant reductions in MLE. Smaller cigarette circumferences reduced sidestream toxicant yields and modified the balance of mainstream smoke chemistry with reduced levels of aromatic amines and benzo[a]pyrene but increased yields of formaldehyde. Smaller circumference cigarettes also had lower mainstream yields of volatile toxicants. Longer cigarette filters containing increased levels of high-activity carbon (HAC) showed reduced machine-smoking yields of volatile toxicants: with up to 97% removal for some volatile toxicants at higher HAC loadings. Split-tipping was combined with optimal filter length and cigarette circumference in an RTP cigarette that gave significantly lower mainstream (up to ~90%) and sidestream (predominately 20%–60%) smoke yields of numerous toxicants as compared with a commercial comparator cigarette under machine-smoking conditions. Significantly lower mainstream and sidestream smoke toxicant yields were observed for an RTP cigarette comprising several toxicant reducing technologies; these observations warrant further evaluation in clinical studies where real-world relevance can be tested using biomarkers of exposure and physiological effect.Electronic supplementary materialThe online version of this article (doi:10.1186/2193-1801-3-374) contains supplementary material, which is available to authorized users.

Highlights

  • Epidemiological studies find that the health risks of cigarette smoking are dose-related and increase with both duration of smoking and level of daily consumption (Doll et al 1994)

  • potential reduced-exposure products (PREPs) were defined as products that substantially reduce exposure to one or more tobacco smoke toxicants as compared to exposures resulting from traditional tobacco products, and, that as a result, might be reasonably expected to reduce the risk of one or more specific diseases or other adverse health effects as compared to the risks associated with use of traditional tobacco products

  • Split-tipping ventilation system Reduced ventilation dependency on flow rate Cigarette filter ventilation is used to dilute, during a puff, mainstream smoke generated in the tobacco burning zone with air entering through holes or perforations in the filter tipping paper, thereby reducing mainstream smoke yields (Norman 1974)

Read more

Summary

Introduction

Epidemiological studies find that the health risks of cigarette smoking are dose-related and increase with both duration of smoking and level of daily consumption (Doll et al 1994). The health risks result from repeated and prolonged exposure to a range of tobacco smoke toxicants, of which more than 150 have been identified (Fowles and Dybing 2003; Green et al 2007), in the diverse mixture of more than 6000 constituents that comprises cigarette smoke (Rodgman and Perfetti 2013). The US FDA subsequently released draft guidelines on MRTPs (US Food and Drug Administration 2012) that lays a framework for future regulatory approval of such products Both the IOM and FDA have cited the necessity of examining the effects of potential MRTPs on the health of individual tobacco users and the population as a whole to determine MRTPs’ possible contribution to tobacco harm reduction

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.